Press releases and News

2022-11-16 09:05
The European Society of Anaesthesiology and Intensive Care (ESAIC) strongly recommends the use of quantitative neuromuscular monitoring to prevent complications related to muscle relaxants. Senzime’s TetraGraph® system fulfills these new guidelines...
2022-11-15 10:00 Regulatory
Uppsala, November 15, 2022. Senzime AB (publ) will give an update at today’s investor event on the strategy following the acquisition of Respiratory Motion (RMI), present the growth opportunities in the market given the new US and European clinical...
2022-11-10 14:30
Senzime AB (publ) invites investors, financial analysts and media to a digital investor event on November 15, 2022, at 13:00-15:00 CET. Pia Renaudin, CEO, will together with Kay Krüger (Business manager ExSpiron products) and Sorin J. Brull (Professor...
2022-11-10 08:30 Regulatory Interim
Press release: Uppsala, 10 November 2022. Senzime AB's (publ) interim report for January - September 2022 is now available on the company's website www.senzime.com. Financial information July - September 2022 Financial information January - September...
2022-10-27 10:00
Uppsala, October 27, 2022. Senzime AB (publ) today announced that the American Society of Anesthesiologists (ASA) has voted on final approval of clinical guidelines for monitoring and reversal of neuromuscular blockade. This is the first time that ASA...
2022-10-25 10:00
Senzime AB (publ) invites investors, financial analysts and media to a digital investor event on November 15, 2022, in the afternoon. The purpose is to give an update of the strategy following the acquisition of Respiratory Motion, describe the market...
2022-09-07 11:50
Uppsala, Sweden. September 7, 2022: Senzime today announced that a study published ahead of print in the Saudi Journal of Anesthesia concludes that TetraGraph, the company’s electromyography (EMG)-based monitor, is effective for monitoring neuromuscular...
2022-08-31 17:06 Regulatory
The extraordinary general meeting in Senzime AB (publ), corp. reg. no 556565-5734 (the “Company”) was held on 31 August 2022 by voting in advance, whereby the shareholders primarily resolved on the following matter. Board of directors The...
2022-08-18 07:55 Regulatory
Press release: Uppsala, August 18, 2022. Senzime today announces that the company’s TetraGraph® -system has now received FDA 510k-clearance for use in children with the disposable sensor TetraSens Pediatric. Senzime can thus broaden the indication...
2022-08-05 08:30
News: Uppsala, August 5, 2022. Senzime announces today the launch of TetraGraph® Xcom, a solution that enables communication between the TetraGraph® and Philips Capsule Medical Device Information Platform (MDIP). The integration enables the electronic...

Contact us

Want to know more?

How can Senzime’s innovative patient monitoring solutions help to eliminate in-hospital complications?
Contact us today.